These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 6749458)

  • 1. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.
    Rossi-Fanelli F; Riggio O; Cangiano C; Cascino A; De Conciliis D; Merli M; Stortoni M; Giunchi G
    Dig Dis Sci; 1982 Oct; 27(10):929-35. PubMed ID: 6749458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective amono acid solutions in hepatic encephalopathy treatment (a preliminary report).
    Fiaccadori F; Ghinelli F; Pelosi G; Sacchini D; Vaona GL; Zeneroli ML; Rocchi E; Santunione V; Gibertini P; Ventura E
    Ric Clin Lab; 1980; 10(2):411-22. PubMed ID: 7455531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched chain amino acid therapy in liver disease.
    Maddrey WC
    J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma amino acids in patients with liver cirrhosis treated with lactulose].
    Giardina MG; Matarazzo M; Prantera T; Verre C; De Marco F
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2309-16. PubMed ID: 6529509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
    Rossi Fanelli F; Cangiano C; Capocaccia L; Cascino A; Ceci F; Muscaritoli M; Giunchi G
    Gut; 1986 Nov; 27 Suppl 1(Suppl 1):111-5. PubMed ID: 3539709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
    Ferenci P; Funovics J; Wewalka F
    Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of coma in liver cirrhosis].
    Manenti F; Ferrari A
    Clin Ter; 1975 Jul; 74(1):3-12. PubMed ID: 1222514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Gluud LL; Dam G; Borre M; Les I; Cordoba J; Marchesini G; Aagaard NK; Vilstrup H
    Metab Brain Dis; 2013 Jun; 28(2):221-5. PubMed ID: 23275147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
    Alsahhar JS; Rahimi RS
    Curr Opin Gastroenterol; 2019 May; 35(3):145-154. PubMed ID: 30893082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis.
    Vilstrup H; Gluud C; Hardt F; Kristensen M; Køhler O; Melgaard B; Dejgaard A; Hansen BA; Krintel JJ; Schütten HJ
    J Hepatol; 1990 May; 10(3):291-6. PubMed ID: 2195106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmapheresis and amino acid mixtures of "Aminosteril-Hepa" type preparations in treating hepatic encephalopathy].
    Boroń P; Flisiak R; Bobrowska E; Hilgier W; Szpakowicz T; Pytel B
    Pol Tyg Lek; 1991 Dec 26-30; 46(50-52):984-6. PubMed ID: 1669187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of cirrhotic encephalopathy].
    Thaler H
    Med Chir Dig; 1976; 5(3):149-51. PubMed ID: 1004044
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
    Morgan MY; Hawley KE
    Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids--a case report.
    Fukuda K; Yao H; Murai K; Ibayashi S; Fujishima M
    Fukuoka Igaku Zasshi; 1999 Dec; 90(12):464-9. PubMed ID: 10655667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.